Selected article for: "human sample and serum sample"

Author: Ria Lassaunière; Anders Frische; Zitta B Harboe; Alex CY Nielsen; Anders Fomsgaard; Karen A Krogfelt; Charlotte S Jørgensen
Title: Evaluation of nine commercial SARS-CoV-2 immunoassays
  • Document date: 2020_4_10
  • ID: 8cg5yj20_15
    Snippet: The specificity of the six POC tests were evaluated primarily on control samples that showed some crossreactivity in the SARS-CoV-2 ELISA assays; the number of control sera tested varied between the different POC tests ( Table 1 ). The POC tests manufactured by Dynamiker Biotechnology, CTK Biotech, AutoBio Diagnostics and Artron Laboratories had a 100% specificity, whereas the test from Acro Biotech and Hangzhou AllTest Biotech had a specificity .....
    Document: The specificity of the six POC tests were evaluated primarily on control samples that showed some crossreactivity in the SARS-CoV-2 ELISA assays; the number of control sera tested varied between the different POC tests ( Table 1 ). The POC tests manufactured by Dynamiker Biotechnology, CTK Biotech, AutoBio Diagnostics and Artron Laboratories had a 100% specificity, whereas the test from Acro Biotech and Hangzhou AllTest Biotech had a specificity of 80% and 87%, respectively. For the latter two tests, crossreactivity was only observed for IgM. The Acro Biotech test cross-reacted with a control serum sample from a human coronavirus HKU1 patient.

    Search related documents:
    Co phrase search for related documents
    • control sample and SARS ELISA assay: 1
    • control sample and serum sample: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13
    • control sera and human coronavirus: 1, 2
    • control sera and poc test: 1
    • control sera and SARS ELISA assay: 1, 2, 3
    • control sera and test control sera: 1, 2, 3, 4
    • control sera and test cross: 1
    • different poc test and poc test: 1, 2
    • different poc test and POC test specificity: 1
    • HKU1 patient and human coronavirus: 1, 2, 3, 4
    • HKU1 patient and human coronavirus HKU1 patient: 1
    • human coronavirus and SARS ELISA assay: 1, 2, 3, 4
    • human coronavirus and serum sample: 1, 2
    • human coronavirus and test cross: 1, 2, 3, 4, 5, 6
    • poc test and SARS ELISA assay: 1
    • poc test and serum sample: 1
    • poc test and test cross: 1
    • SARS ELISA assay and serum sample: 1, 2
    • SARS ELISA assay and test cross: 1, 2